Jump to navigation
Promoting world class health research that has global impact.
The Princess Margaret Drug Development Program – Phase 1 (DDP1) is excited to announce their first symposium on Anticancer Developmental Therapeutics on Friday, November 1, 2024 in the MaRS Auditorium, 101 College Street, Toronto, Canada. The one-day symposium will have talks focused on immunotherapies and cancer therapeutics.
Registration Closes: Friday, September 27, 2023.